These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Treatment
137 results:

  • 1. BMP Stimulation Differentially Affects Phosphorylation and Protein Stability of β-Catenin in Breast cancer Cell Lines.
    Ilhan M; Hastar N; Kampfrath B; Spierling DN; Jatzlau J; Knaus P
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731813
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational profile evaluates metastatic capacity of Chinese colorectal cancer patients, revealed by whole-exome sequencing.
    Yang Y; Chen J; Peng H; Xiao Z; Xu W; Zheng M; Li Z; Cao P
    Genomics; 2024 May; 116(3):110809. PubMed ID: 38492821
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Hammarström K; Nunes L; Mathot L; Mezheyeuski A; Lundin E; Korsavidou Hult N; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Int J Cancer; 2024 Jul; 155(1):40-53. PubMed ID: 38376070
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
    Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
    J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An overview of chemically induced rodent models for sporadic colorectal cancer: Histopathological and translational perspectives.
    Sarmiento-Machado LM; Rodrigues MAM; Romualdo GR; Barbisan LF
    Histol Histopathol; 2024 Jun; 39(6):691-702. PubMed ID: 38179656
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sotorasib with panitumumab in chemotherapy-refractory KRAS
    Kuboki Y; Fakih M; Strickler J; Yaeger R; Masuishi T; Kim EJ; Bestvina CM; Kopetz S; Falchook GS; Langer C; Krauss J; Puri S; Cardona P; Chan E; Varrieur T; Mukundan L; Anderson A; Tran Q; Hong DS
    Nat Med; 2024 Jan; 30(1):265-270. PubMed ID: 38177853
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Local Therapy Improves Survival for Early Recurrence After Resection of colorectal Liver Metastases.
    Boyev A; Tzeng CD; Maki H; Arvide EM; Mrema DE; Jain AJ; Haddad A; Lendoire M; Malik N; Odisio BC; Chun YS; Tran Cao HS; Vauthey JN; Newhook TE
    Ann Surg Oncol; 2024 Apr; 31(4):2547-2556. PubMed ID: 38148351
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Loss of SETD2 aggravates colorectal cancer progression caused by smad4 deletion through the RAS/ERK signalling pathway.
    Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in colorectal and Pancreatic cancers Carrying smad4 Loss.
    Erasimus H; Kolnik V; Lacroix F; Sidhu S; D'Agostino S; Lemaitre O; Rohaut A; Sanchez I; Thill G; Didier M; Debussche L; Marcireau C
    Cancer Res Commun; 2023 May; 3(5):780-792. PubMed ID: 37377893
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PRMT5 methylating smad4 activates TGF-β signaling and promotes colorectal cancer metastasis.
    Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
    Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lantern-shaped flexible RNA origami for smad4 mRNA delivery and growth suppression of colorectal cancer.
    Hu M; Feng C; Yuan Q; Liu C; Ge B; Sun F; Zhu X
    Nat Commun; 2023 Mar; 14(1):1307. PubMed ID: 36894556
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis Of Common Somatic Mutations In colorectal Carcinoma And Associated Dysregulated Pathwaysarts.
    Hassan S; Khatoon A; Bukhari U; Mirza T
    J Ayub Med Coll Abbottabad; 2023; 35(1):137-143. PubMed ID: 36849394
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Harpain F; Dawoud C; Wimmer K; Schlager L; Kirchnawy S; Rizk D; Girgis K; Mittermair E; Oberndorfer F; Wöran K; Riss S; Stift A; Stift J
    Ann Surg Oncol; 2023 Jun; 30(6):3517-3527. PubMed ID: 36757514
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Cytokine Network in colorectal cancer: Implications for New treatment Strategies.
    Braumüller H; Mauerer B; Andris J; Berlin C; Wieder T; Kesselring R
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611932
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
    Szász I; Kiss T; Mokánszki A; Koroknai V; Deák J; Patel V; Jámbor K; Ádány R; Balázs M
    Mol Cell Probes; 2023 Feb; 67():101888. PubMed ID: 36513244
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clonal evolution and expansion associated with therapy resistance and relapse of colorectal cancer.
    S A; Chakraborty A; Patnaik S
    Mutat Res Rev Mutat Res; 2022; 790():108445. PubMed ID: 36371022
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The first comprehensive genomic characterization of rectal squamous cell carcinoma.
    Astaras C; De Vito C; Chaskar P; Bornand A; Khanfir K; Sciarra A; Letovanec I; Corro C; Dietrich PY; Tsantoulis P; Koessler T
    J Gastroenterol; 2023 Feb; 58(2):125-134. PubMed ID: 36357817
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. smad4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, colorectal cancer Growth, and Metastasis.
    Loevenich LP; Tschurtschenthaler M; Rokavec M; Silva MG; Jesinghaus M; Kirchner T; Klauschen F; Saur D; Neumann J; Hermeking H; Jung P
    Cancer Res; 2022 Dec; 82(24):4604-4623. PubMed ID: 36219392
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA.
    Ye LF; Huang ZY; Chen XX; Chen ZG; Wu SX; Ren C; Hu MT; Bao H; Jin Y; Wang F; Wang FH; Du ZM; Wu X; Ju HQ; Shao Y; Li YH; Xu RH; Wang DS
    Drug Resist Updat; 2022 Dec; 65():100883. PubMed ID: 36202008
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer.
    Maslankova J; Vecurkovska I; Rabajdova M; Katuchova J; Kicka M; Gayova M; Katuch V
    World J Gastroenterol; 2022 Sep; 28(33):4744-4761. PubMed ID: 36156927
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.